MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 234 filers reported holding MYRIAD GENETICS INC in Q1 2016. The put-call ratio across all filers is 2.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $8,304,000 | -15.2% | 267,875 | +2.4% | 0.08% | -21.3% |
| Q1 2016 | $9,787,000 | -12.9% | 261,487 | +0.4% | 0.11% | -16.3% |
| Q4 2015 | $11,242,000 | +15.4% | 260,482 | +0.2% | 0.13% | +10.3% |
| Q3 2015 | $9,743,000 | +11.3% | 259,954 | +0.9% | 0.12% | +15.8% |
| Q2 2015 | $8,757,000 | +6.2% | 257,649 | +3.2% | 0.10% | 0.0% |
| Q1 2015 | $8,248,000 | -68.8% | 249,716 | -67.8% | 0.10% | -49.0% |
| Q4 2014 | $26,413,000 | +76.6% | 775,473 | +100.0% | 0.20% | -23.8% |
| Q3 2014 | $14,958,000 | -0.7% | 387,826 | +0.2% | 0.26% | -6.8% |
| Q2 2014 | $15,058,000 | +14.6% | 386,908 | +0.6% | 0.28% | -0.4% |
| Q1 2014 | $13,143,000 | +67.0% | 384,413 | +2.5% | 0.28% | +4.5% |
| Q4 2013 | $7,868,000 | +487.6% | 375,033 | +558.0% | 0.27% | +523.3% |
| Q3 2013 | $1,339,000 | -78.5% | 56,998 | -75.4% | 0.04% | -73.9% |
| Q2 2013 | $6,227,000 | – | 231,727 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 4,000,000 | $45,360,000 | 2.60% |
| Tieton Capital Management, LLC | 166,441 | $1,887,000 | 2.36% |
| S&T BANK/PA | 315,835 | $3,582,000 | 0.82% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,194,204 | $24,882,000 | 0.60% |
| XTX MARKETS LLC | 14,807 | $168,000 | 0.57% |
| Glenview Capital Management | 1,810,727 | $20,534,000 | 0.57% |
| EARNEST PARTNERS LLC | 4,761,082 | $53,991,000 | 0.51% |
| AIMZ Investment Advisors, LLC | 42,685 | $484,000 | 0.31% |
| DUALITY ADVISERS, LP | 163,717 | $1,857,000 | 0.17% |
| Engineers Gate Manager LP | 219,922 | $2,494,000 | 0.13% |